Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's disease-Reference-Cited by-同舟云学术

Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's disease

Published:2021-02 Issue: Volume:83 Page:22-30
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Heckman Michael G.,Labbé Catherine,Kolicheski Ana L.,Soto-Beasley Alexandra I.,Walton Ronald L.,Valentino Rebecca R.^ORCID,Brennan Emily R.,Johnson Patrick W.,Baheti Saurabh,Sarangi Vivekananda,Ren Yingxue,Uitti Ryan J.,Wszolek Zbigniew K.,Ross Owen A.

Funder

National Institute of Neurological Disorders and Stroke

U.S. Department of Defense

Publisher

Elsevier BV

Subject

Clinical Neurology,Geriatrics and Gerontology,Neurology

Reference37 articles.

1. Advances in the genetics of Parkinson disease;Trinh;Nat. Rev. Neurol.,2013

2. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies;Nalls;Lancet (London, England),2011

3. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease;Nalls;Nat. Genet.,2014

4. A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci;Chang;Nat. Genet.,2017

5. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies;Nalls;the Lancet. Neurology,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LRRK2 in Parkinson's disease: upstream regulation and therapeutic targeting;Trends in Molecular Medicine;2024-08

2. Leucine‐rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule‐associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism;MedComm;2023-11-20

3. Regulation of LRRK2 mRNA stability by ATIC and its substrate AICAR through ARE‐mediated mRNA decay in Parkinson's disease;The EMBO Journal;2023-06-27

4. The impact of common variants on gene expression in the human brain: from RNA to protein to schizophrenia risk;2023-06-05

5. Lifestyle Factors and Parkinson Disease Risk;Neurology;2021-10-14